Assessment of High Dose Transdermal Nicotine for Fast Metabolizers of Nicotine
NCT00956943
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
87
Enrollment
OTHER
Sponsor class
Conditions
Nicotine Dependence
Interventions
DRUG:
Nicoderm CQ transdermal nicotine
DRUG:
placebo
Sponsor
University of Pennsylvania